.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Merck
Boehringer Ingelheim
Healthtrust
Johnson and Johnson
Novartis
UBS
Cantor Fitzgerald
Teva
Express Scripts

Generated: July 21, 2017

DrugPatentWatch Database Preview

ZOMIG Drug Profile

« Back to Dashboard

Which patents cover Zomig, and what generic Zomig alternatives are available?

Zomig is a drug marketed by Astrazeneca and IPR and is included in three NDAs. There are two patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in ZOMIG is zolmitriptan. There are twenty drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the zolmitriptan profile page.

Summary for Tradename: ZOMIG

Patents:2
Applicants:2
NDAs:3
Suppliers / Packagers: see list4
Bulk Api Vendors: see list55
Clinical Trials: see list7
Patent Applications: see list2,625
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZOMIG at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca
ZOMIG
zolmitriptan
SPRAY;NASAL021450-003Sep 16, 2013RXYesNo6,750,237*PED► SubscribeY► Subscribe
Ipr
ZOMIG
zolmitriptan
TABLET;ORAL020768-001Nov 25, 1997ABRXYesNo► Subscribe► Subscribe
Astrazeneca
ZOMIG
zolmitriptan
SPRAY;NASAL021450-004Sep 30, 2003RXYesYes6,750,237*PED► SubscribeY► Subscribe
Ipr
ZOMIG
zolmitriptan
TABLET;ORAL020768-002Nov 25, 1997ABRXYesYes► Subscribe► Subscribe
Astrazeneca
ZOMIG
zolmitriptan
SPRAY;NASAL021450-003Sep 16, 2013RXYesNo7,220,767*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ZOMIG

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ipr
ZOMIG
zolmitriptan
TABLET;ORAL020768-001Nov 25, 19975,863,935*PED► Subscribe
Ipr
ZOMIG
zolmitriptan
TABLET;ORAL020768-002Nov 25, 19975,466,699*PED► Subscribe
Astrazeneca
ZOMIG
zolmitriptan
SPRAY;NASAL021450-004Sep 30, 20035,466,699*PED► Subscribe
Ipr
ZOMIG
zolmitriptan
TABLET;ORAL020768-002Nov 25, 19975,863,935*PED► Subscribe
Ipr
ZOMIG
zolmitriptan
TABLET;ORAL020768-001Nov 25, 19975,466,699*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: ZOMIG

Drugname Dosage Strength RLD Submissiondate
zolmitriptanNasal Spray5 mg/sprayZomig11/14/2013
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Argus Health
Accenture
Cipla
Boehringer Ingelheim
Baxter
McKesson
Covington
Chinese Patent Office
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot